PHILADELPHIA--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX: HEB) announced that its Board of Directors has engaged McGladrey & Pullen, LLP as the Company’s new independent registered public accounting firm following the filing of its quarterly report on Form 10-Q for the period ended September 30, 2006.
